Promising anti-obesity pill
Rimonabant is a drug from a French pharma outfit whose clinical trials show remarkable results in controlling appetite with minimal side-effects. It's being hailed as a drug with the potential to practically address the obesity epidemic.Dr. Despres led a trial of rimonabant in 1,036 overweight patients at high risk for heart problems. All patients were told to cut their food intake by 600 calories daily. Those who received a 20-mg dose lost an average of 20 pounds and trimmed their waistlines by three inches in one year. Those given placebos lost an average of five pounds.Link
Share this post
Where not otherwise specified, this work is licensed under a Creative Commons License permitting non-commercial sharing with attribution. Boing Boing is a trademark of Happy Mutants LLC in the United States and other countries.